Immunoglobulin Market | Set to Encounter Paramount Growth at a CAGR of 6.6% from 2018 to 2025

Immunoglobulin Market | Set to Encounter Paramount Growth at a CAGR of 6.6% from 2018 to 2025

Immunoglobulin Market : Global Opportunity Analysis and Industry Forecast, 2018 – 2025
Increase in the number of hemophilic patients, improved immunoglobulin production using advanced technologies, and enhanced purification techniques with better plasma yield, and rise in prevalent diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, and others would drive the growth of the global immunoglobulin market.

According to a new report published by Allied Market Research, titled,Immunoglobulin Market by Application, Mode of Delivery, Products Type and Geography: Global Opportunity Analysis and Industry Forecast, 2018 – 2025,”the immunoglobulin market accounted for $9,972.9 million in 2017, and is projected to reach $16,694.7 million by 2025, registering a CAGR of 6.6% from 2018 to 2025.

Immunoglobulin is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. Immunoglobulin is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology. Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in immunoglobulin indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the Immunoglobulin market.

Request Sample Report at:

Hypogammaglobulinemia segment to dominate in terms of revenue by 2025 

Among applications, hypogammaglobulinemia segment contributed the highest market share of 21% in 2017 and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the growing incidence of hypogammaglobulinemia worldwide. However, myasthenia gravis segment is projected to grow at the fastest CAGR of 10.4% from 2018 to 2025. The report also analyzes chronic inflammatory demyelinating polyneuropathy, primary Immunodeficiency diseases, multifocal motor neuropathy, ITP, inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome and others segments.

Intravenous segment to dominate through the forecast period 

Among various modes of delivery, the intravenous segment accounted for 90% share of the total market revenue in 2017 and is expected to maintain its dominance through the study period. High bioavailability of immunoglobulins and rapid absorption rate offered by intravenous mode of delivery drive the growth of this segment. On the other hand, the suncutaneous segment would grow at the fastest CAGR of 7.5% during the forecast period.

For Purchase Enquiry:

North America: highest revenue-generating region, LAMEA: fastest growing segment 

North America contributed nearly half of the total market share in 2017 and would continue to maintain its dominance through 2025. The presence of large plasma production units and high adoption of immunoglobulin in the region boost the market growth. However, Latin America, Middle East and Africa (LAMEA) would register the highest CAGR of 10.3% from 2018 to 2025. The other regions analyzed in the study include Asia-Pacific and Europe.

Prominent players of the industry 

The report presents a detailed analysis of the key players of the global immunoglobulin market including, Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products Inc., Shire (Baxalta), and Bayer Healthcare. These players have adopted new product launches, joint ventures, expansions, mergers & acquisitions, partnerships, and collaborations to gain stronghold in the industry.

Similar Reports:

Over the Counter (OTC) Drugs & Dietary Supplements Market – Global Opportunity Analysis and Industry Forecast, 2017-2023

Acne Medication Market – Global Opportunity Analysis and Industry Forecast, 2018-2025


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Media Contact
Company Name: Allied Market Research
Contact Person: David Correa
Email: Send Email
Phone: +1-800-792-5285
Address:5933 NE Win Sivers Drive #205
City: Portland
State: OR 97220
Country: United States